COVID-19 Is a Coronary Artery Disease Risk Equivalent and Exhibits a Genetic Interaction With ABO Blood Type | Arteriosclerosis, Thrombosis, and Vascular Biology
COVID-19 significantly raises the risk of major adverse cardiac events, including myocardial infarction and stroke, especially in hospitalized patients.
The risk of thrombotic events is higher in individuals with non-O blood types.
“The risk of MACE (major adverse cardiac events)was elevated in COVID-19 cases at all levels of severity”
The risk of MACE was elevated in COVID-19 cases at all levels of severity
